Hi SK,
C79 released its 1H result and updated FY25 guidance this week. Revenue has been revised to the low end of the range, while earnings (EBITDA) is tracking below the mid-point. This looks largely related to deployment timing of their machines, which has been a trend in recent times and the reason we sold out last October. They deployed +5 in the 1H and are currently deploying +2 currently. On the analyst call, management highlighted that most of the units contracted in 1H will be deployed during FY25. This implies another +2 in the later months of 2H so it looks like +10 units will be deployed in FY25 which is lower than expected, by about 20%. The unit volumes are relatively small, so a reduction of 2 units is quite meaningful, plus, it implies they will struggle to deploy the +20 in FY26 that many had thought they would i.e. that would imply 100% growth on FY25 assuming they hit +10 this year.
- For now, the trends are not favourable, and the reasons why we took a ~15% loss on the position when we sold, are still persisting today.